Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity This top executive at Harmony Biosciences previous sold all of his direct shares in the company in early January 2026. But towards the end of the month, some options and restricted stock units vested, and everything changed.
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 The Chief Scientific Officer of Scholar Rock Holding Corp has made multiple filings regarding disposals in January 2026, but this should not alarm investors.
3 Questions Investors Should Answer Before Buying Beyond Meat Stock Beyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.
Market At Risk Of Correcting In A 'Risk-Off' Reset? Stocks have been stuck in a compressing trading range for the past several months.
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.
Should You Buy Nio Stock While It's Below $5 a Share? Nio is an innovative auto company operating in the world's largest auto market, but I'm still bearish on it.
Ford, Xiaomi Deny JV Talks Even As Jim Farley Expressed Admiration For Chinese EVs While Flagging Them As Competitive Threat Ford reportedly had preliminary discussions with Xiaomi about a joint venture, aiming to facilitate Chinese carmakers' entry into the U.S. market.
Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.
Trump Limits DHS Intervention In Protests To Local Requests, Says Will Not Participate In Any Circumstance 'Until…' Trump announced Homeland Security will only intervene in Dem cities' protests if asked, while Fed buildings will be protected as backup.
Tesla Rival Waymo Targets $16 Billion Funding Round, Valuation Nears $110 Billion: Report Despite recent safety concerns, Waymo continues to expand operations and faces potential impact on industry.
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes The chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the reason was for something very simple.
1 Underrated Reason Netflix's Growth Story Isn't Over The streaming giant's stock is trading at much lower levels than it was a year ago.
Pete Buttigieg Says Trump 'Failed To Bring Down Prices,' Warns Affordability Crisis Is Hitting American Families Transportation Secretary Pete Buttigieg criticized Trump administration and Republicans for rising costs, stalled healthcare relief.
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock performance. But the sale is not what it seems.
4 Ways to Set Your 401(k) Up for Success in 2026 With the right strategy, you can grow your savings nicely this year.
Investment Firm Bouvel Raised Its Stake in This ETF by $8 Million. Is It a Buy? This actively managed fixed income ETF targets diversified bond exposure and reported a 5.09% annualized yield in its latest filing.
